Metabolic Effects of Exogenous 3-hydroxybutyrate in Patients With Type 1 Diabetes and Healthy Controls
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetic Ketoacidosis
- Type 1 Diabetes Mellitus
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: Crossover design in 2 different groups, patients with type 1 diabetes and healthy controls.Masking: Single (Participant)Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 18 years and 60 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04656236
- Collaborators
- Aarhus University Hospital
- Investigators
- Study Director: Niels Møller, Professor Department of Endocrinology and Steno Diabetes Center Aarhus, Aarhus University Hospital Principal Investigator: Maj Bangshaab, MD Steno Diabetes Center Aarhus and Aarhus University
Get Well Soon